Please assess the completion status of the following clinical trial:

Trial Title: Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients with schizophrenia treated with clozapine; age 19-79~Exclusion Criteria:~* pregnant women, personal history of/or comorbid eating disorders

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Integrated care (Type: EXPERIMENTAL): Provide on-site internal medicine evaluation, treatment and follow up of metabolic syndrome for patients in Clozapine Clinic
- Usual Care (Type: OTHER): Follow the 8-month outcome of schizophrenia patients with metabolic syndrome treated in the community

Based on this trial design, predict the completion outcome and termination type (if applicable).